BFH772 (VEGFR2 Inhibitor): Product Overview
BFH772 (SKU B6199; CAS 890128-81-1) is listed by APExBIO as a small-molecule VEGFR2 inhibitor. The catalog identifies it as 6-((6-(hydroxymethyl)pyrimidin-4-yl)oxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide, with molecular formula C23H16F3N3O3 and molecular weight 439.39.
Conceptual scope
Within the supplied product description, BFH772 is positioned as a VEGFR2 signaling pathway inhibitor for conceptual research on receptor-linked vascular biology and angiogenesis. Terms such as angiogenesis inhibitor, tumor angiogenesis research compound, and anti-angiogenic agent describe the vendor’s intended research scope rather than independently established performance.
Evidence status and limitations
The catalog reports a VEGFR2 kinase IC50 of 3 nM, selectivity comparisons with related receptors and other kinases, and activity in animal tumor models. However, no matched research paper was provided for review. The assay context, controls, statistical analysis, endpoint definitions, and provenance of these claims therefore cannot be assessed here. They should be treated as supplier-reported information, not as independently validated efficacy or clinical evidence.
The product page also reports quality-control documentation and material specifications. These details establish catalog identity and supply information but do not demonstrate reproducible biological activity across assays, cell types, animal models, or clinical settings. No therapeutic recommendation or practical experimental guidance is supported by the available evidence.